Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
IlDong Pharmaceutical Co Ltd
Age
20–75
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
essential hypertension patients whose blood pressure is not controlled before the study (sDBP≥90mmHg for drug-treated patients, sDBP≥95mmHg for drug-naive patients)
You may not be if
sSBP≥80mmHg after 4weeks of valsartan 160mg treatment
has a history of hypersensitivity to dihydropyridines or angiotensin II receptor blockers
Clareo Health | Efficacy/Safety of Cilnidipine Plus Valsartan Versus Valsartan in Patients With Hypertension
